About Technology Issues FAQ

Links

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study

Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.